Results 91 to 100 of about 2,336 (164)

Preclinical Immunogenicity of a 6-Valent GBS Glycoconjugate Vaccine from a Repeat-Dose GLP Toxicology Study. [PDF]

Vaccines (Basel)
Bajracharya A, Chellappan G, Seal F, Zhao Y, Chalke G, Chowdhury N, Seth H, Gan J, Guo S, Pinder K, Chang F, Huff D, Mydland A, Wright C, Conceicao L, Balasundaram W, Raghunandan R, Datta A, Kapre SV.   +18 more
europepmc   +1 more source

Sequential Linkage of Carbohydrate Antigens to Mimic Capsular Polysaccharides: Toward Semisynthetic Glycoconjugate Vaccine Candidates against Streptococcus pneumoniae Serotype 14. [PDF]

ACS Chem Biol, 2020
Seco BMS, Xu FF, Grafmüller A, Kottari N, Pereira CL, Seeberger PH.   +5 more
europepmc   +1 more source

The Salmonella Paratyphi A O-Antigen Glycoconjugate Vaccine Is Able to Induce Antibodies with Bactericidal Activity Against a Panel of Clinical Isolates. [PDF]

Vaccines (Basel)
Pinto M, Durante S, Carducci M, Massai L, Alfini R, Mylona E, Karkey A, Baker S, Micoli F, Giannelli C, Rossi O, Rondini S.   +11 more
europepmc   +1 more source

Semisynthetic Glycoconjugate Vaccine Candidates against <i>Cryptococcus neoformans</i>. [PDF]

ACS Infect Dis
Crawford CJ, Liporagi-Lopes L, Coelho C, Santos Junior SR, Moraes Nicola A, Wear MP, Vij R, Oscarson S, Casadevall A.   +8 more
europepmc   +1 more source

Semisynthetic Glycoconjugate Vaccine Lead against <i>Klebsiella pneumoniae</i> Serotype O2afg Induces Functional Antibodies and Reduces the Burden of Acute Pneumonia. [PDF]

J Am Chem Soc
Shen D, Seco BMS, Teixeira Alves LG, Yao L, Bräutigam M, Opitz B, Witzenrath M, Fries BC, Seeberger PH.   +8 more
europepmc   +1 more source

Optimization of the Synthesis and Conjugation of the Methyl Rhamnan Tip of Pseudomonas aeruginosa A-Band Polysaccharide and Immunogenicity Evaluation for the Continued Development of a Potential Glycoconjugate Vaccine. [PDF]

ACS Infect Dis
Jamshidi MP, Cairns C, Huan Khieu N, Chan K, St Michael F, Cox A, Sauvageau J.   +6 more
europepmc   +1 more source

Glycoconjugate vaccine using a genetically modified O antigen induces protective antibodies to Francisella tularensis. [PDF]

Proc Natl Acad Sci U S A, 2019
Stefanetti G, Okan N, Fink A, Gardner E, Kasper DL.   +4 more
europepmc   +1 more source

A semisynthetic Streptococcus pneumoniae serotype 8 glycoconjugate vaccine. [PDF]

Sci Transl Med, 2017
Schumann B, Hahm HS, Parameswarappa SG, Reppe K, Wahlbrink A, Govindan S, Kaplonek P, Pirofski LA, Witzenrath M, Anish C, Pereira CL, Seeberger PH.   +11 more
europepmc   +1 more source

Semisynthetic glycoconjugate vaccine candidate against Streptococcus pneumoniae serotype 5. [PDF]

Proc Natl Acad Sci U S A, 2017
Lisboa MP, Khan N, Martin C, Xu FF, Reppe K, Geissner A, Govindan S, Witzenrath M, Pereira CL, Seeberger PH.   +9 more
europepmc   +1 more source

Peptide adjacent to glycosylation sites impacts immunogenicity of glycoconjugate vaccine. [PDF]

Oncotarget, 2018
Ma Z, Zhang H, Wang PG, Liu XW, Chen M.
europepmc   +1 more source